Bacterial infection pathways

Bacterial infection pathways encompass the diverse molecular strategies employed by bacteria to establish infection, survive within a host, and cause disease. These pathways involve critical steps such as adhesion to host tissues, the secretion of virulence factors, and the subversion of host cellular processes to facilitate bacterial entry and replication (KEGG: Bacterial invasion of epithelial cells, 2023). While the term refers to a broad biological category rather than a single molecular entity, these pathways contain numerous specific proteins that serve as essential therapeutic targets, including penicillin-binding proteins, DNA gyrase, and ribosomal subunits (Nature Reviews Microbiology, 2021). Antibiotics and other antimicrobial agents interact with these specific components to disrupt bacterial viability or virulence, thereby halting the progression of the infection (NIH: Antimicrobial Resistance, 2022). However, the high degree of complexity and the rapid emergence of resistance mechanisms within these pathways pose significant challenges for drug development and clinical management (StatPearls: Antibiotics, 2023). Understanding the interplay between bacterial effectors and host signaling is vital for identifying novel targets that can bypass existing resistance mechanisms.

Other names

Bacterial pathogenesisHost-pathogen interactionsBacterial invasion of epithelial cellsBacterial infectious disease pathways

Antibiotics target specific molecular components within bacterial infection pathways, such as cell wall synthesis enzymes, ribosomal subunits, or DNA topoisomerases, to inhibit bacterial growth or induce cell death.